Prospects of using protein engineering for selective drug delivery into a specific compartment of target cells

AA Rosenkranz, TA Slastnikova - Pharmaceutics, 2023 - mdpi.com
A large number of proteins are successfully used to treat various diseases. These include
natural polypeptide hormones, their synthetic analogues, antibodies, antibody mimetics …

In Silico Analyses, Experimental Verification and Application in DNA Vaccines of Ebolavirus GP-Derived pan-MHC-II-Restricted Epitopes

J Zhang, B Sun, W Shen, Z Wang, Y Liu, Y Sun… - Vaccines, 2023 - mdpi.com
(1) Background and Purpose: Ebola virus (EBOV) is the causative agent of Ebola virus
disease (EVD), which causes extremely high mortality and widespread epidemics. The only …

Preparation of antibodies against TXR1 and construction of a new DNA tumor vaccine

Y Sun, X Zhang, S Yang, C Hu, J Pan, T Liu… - International …, 2022 - Elsevier
Background Taxol-resistance gene 1 (TXR1) is closely correlated with the paclitaxel
resistance in the cancer chemotherapy. However, due to the lack of monoclonal antibodies …

[PDF][PDF] Análisis in silico de un candidato a vacuna multi-epítopo contra viruela del mono usando vaculonogía reversa In silico analysis of a multi-epitope vaccine …

CFM Oyola, BAN Rosero, JP García-López - 2022 - researchgate.net
Introducción. La viruela del mono es una infección zoonótica con una tasa de transmisión
global aumentada durante 2022. Actualmente, la enfermedad no tiene tratamientos …

[引用][C] Prospects of Using Protein Engineering for Selective Drug Delivery into a Specific Compartment of Target Cells. Pharmaceutics 2023, 15, 987

AA Rosenkranz, TA Slastnikova - 2023 - europepmc.org
A large number of proteins are successfully used to treat various diseases. These include
natural polypeptide hormones, their synthetic analogues, antibodies, antibody mimetics …